BrainsWay Ltd., a leader in non-invasive neurostimulation for mental health, announced a strategic collaboration with Inland Psychiatric Medical Group (IPMG) in Southern California. The partnership includes installing BrainsWay Deep TMS systems at IPMG clinics and exploring joint research to enhance interventional psychiatry treatments. This collaboration aims to improve patient outcomes by expanding access to innovative therapies for conditions like depression, OCD, and smoking addiction. The move strengthens BrainsWay's presence in the US and supports its mission to advance mental health care through cutting-edge technology.
BrainsWay's strategic collaboration with Inland Psychiatry Medical Group is noted alongside Pluang's health sector market data. For readers following health stocks, here is Pluang's market snapshot as of Oct 19, 2026 18:01 WIB: out of 150 priced US health-sector stocks, 73 rose and 47 fell today. Notable movers include TNGX at USD 22.48 (+2.00%, typical hold time 4 days), AMLX at USD 26.86 (+1.97%, typical hold time 16 days), and RLAY at USD 16.59 (+1.90%, typical hold time 9 days).
Bill Gross, a serial entrepreneur behind over 175 companies, has launched Idealab.ai, a platform using AI to generate and share over 1.2 million business ideas based on real-world problems. The platform aims to lower barriers to entrepreneurship by h...
The Portnoy Law Firm has launched an investigation into Cardinal Infrastructure Group for possible securities fraud following the company's Q2 2026 financial report. Cardinal revealed a decline in its gross profit margin to 10.8%, down from 13.9% the...
AIOS Tech Inc. announced an agreement to acquire SmartCore Holdings Limited in an all-stock transaction valued at approximately $100 million. The deal will issue 33.3 million AIOS shares to SmartCore's sellers, who will hold about 80% of AIOS shares ...
XBiotech announced positive results from the Phase II TASKIN trial, where their antibody vilamakitug combined with standard chemotherapy improved 12-month overall survival to 61.3% in refractory metastatic colorectal cancer patients, surpassing the s...
Proof and Circle Internet Group demonstrated a new system where AI agents can prove the identity of the person they represent using Proof's x401 open identity protocol and pay merchants in USDC via Circle's x402 payment protocol. This innovation addr...
